Press Releases

Search Press Releases:

Search Input

• All News
• 2022
• 2021
• 2020
• 2019
• 2018
• 2017
• 2016
• 2015
• 2014
• 2013
• 2012
• 2011
• 2010

Tonix Pharmaceuticals Announces Results of Pre-IND Meeting with FDA for TNX-1800 as a Potential Vaccine to Prevent COVID-19

September 13, 2021 • 8:00 AM EDT

Tonix Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference

September 7, 2021 • 7:00 AM EDT

Tonix Pharmaceuticals Announces Results of Pre-IND Meeting with FDA for TNX-102 SL as a Potential Treatment for Long COVID Syndrome, Also Known as Post-Acute Sequelae of COVID-19 (PASC)

August 24, 2021 • 7:00 AM EDT

Tonix Pharmaceuticals Reports Second Quarter 2021 Financial Results and Operational Highlights

August 9, 2021 • 4:45 PM EDT

Tonix Pharmaceuticals Announces Groundbreaking Ceremony for Massachusetts R&D Facility to House the Advanced Development Center (ADC) for Vaccine Programs

August 2, 2021 • 7:00 AM EDT

Tonix Pharmaceuticals Announces Agreement to Acquire Infectious Disease R&D Facility to Accelerate Development of Vaccines and Antiviral Drugs

July 27, 2021 • 7:00 AM EDT

Tonix Pharmaceuticals Announces Outcome of Interim Analysis of Phase 3 RALLY Study of TNX-102 SL for the Management of Fibromyalgia

July 23, 2021 • 4:40 PM EDT

Tonix Pharmaceuticals Announces New Board Member, Carolyn E. Taylor

July 19, 2021 • 7:00 AM EDT

Tonix Pharmaceuticals Added to Russell 2000® and Russell 3000® Indexes

June 28, 2021 • 7:00 AM EDT

Commercial Scale Vaccine Manufacturing Facility Advances In The Bitterfoot

June 24, 2021 • 1:30 PM EDT

• « Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• ...43
• Next »